G
Gossamer Bio, Inc. (GOSS)
NMS – Real vaqt narxi. Valyuta: USD
0.34
+0.00 (0.56%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.34
+0.00 (0.03%)
Bozor oldidan: May 13, 2026, 7:07 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
0.34
+0.00 (0.56%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.34
+0.00 (0.03%)
Bozor oldidan: May 13, 2026, 7:07 AM EDT
Gossamer Bio, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda o'pka gipertenziyasi va o'pka arteriya gipertenziyasini davolash uchun seralutinibni ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniya GB002 ni ishlab chiqmoqda, bu nafas orqali yuboriladigan, kichik molekulali, trombotsitlardan olingan o'sish omili retseptorlari, yoki PDGFR, koloniyani rag'batlantiruvchi omil 1 retseptorlari va c-KIT ingibitori bo'lib, u PAH ni davolash uchun 3-bosqichli klinik sinovda. U GB002 va tegishli zaxira birikmalarini ishlab chiqish va tijoratlashtirish uchun Pulmokine, Inc. bilan litsenziya shartnomalariga ega. Kompaniya ilgari FSG, Bio, Inc. nomi bilan tanilgan va 2017 yilda Gossamer Bio, Inc. nomini o'zgartirgan. Kompaniya 2015 yilda ro'yxatga olingan va San-Diego, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Richard Aranda M.D. | Chief Medical Officer |
| Dr. Robert F. Roscigno Ph.D. | Senior Vice President of Clinical Development of Pulmonary Vascular Disease |
| Mr. Bryan Giraudo | COO & CFO |
| Mr. Christian Waage J.D. | Executive Vice President of Technical Operations & Administration |
| Mr. Faheem Hasnain | Co-Founder, CEO, President & Chairman |
| Mr. Jeff Boerneke | General Counsel & Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-24 | DEFA14A | a20260424-gossxdefa14a.htm |
| 2026-04-09 | 8-K | goss-20260408.htm |
| 2026-03-17 | POSASR | a20260317-gossxposasr.htm |
| 2026-03-17 | POS AM | a20260317-gossxposam.htm |
| 2026-02-23 | 8-K | goss-20260223.htm |
| 2026-01-28 | S-3ASR | a20260128-gossxsx3asr.htm |
| 2025-11-05 | 8-K | goss-20251105.htm |
| 2025-09-25 | 8-K | goss-20250924.htm |
| 2025-08-05 | 8-K | goss-20250805.htm |
| 2025-06-25 | 8-K | goss-20250625.htm |
| Mr. Robert P. Smith | Chief Commercial Officer |
| Ms. Caryn L. Peterson | Executive Vice President of Regulatory Affairs |
| Ms. Deanna Weber | Executive Vice President of Human Resources |
| Ms. Jeanine Anthony | Senior Vice President of Marketing |